Viewing Study NCT02437500


Ignite Creation Date: 2025-12-26 @ 12:17 PM
Ignite Modification Date: 2025-12-31 @ 2:15 PM
Study NCT ID: NCT02437500
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2023-06-13
First Post: 2015-05-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access Program of SER-109 in the Treatment of Adults With Recurrent Clostridioides Difficile Infection (RCDI)
Sponsor: Seres Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module